Ionis Pharmaceuticals (IONS) EBIT Growth (5y) (2014 - 2026)
Ionis Pharmaceuticals (IONS) EBIT Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.01% |
| Dec 31, 2025 | -56.75% |
| Sep 30, 2025 | -34.39% |
| Jun 30, 2025 | 36.29% |
| Mar 31, 2025 | -19.16% |
| Dec 31, 2024 | -19.38% |
| Sep 30, 2024 | -127.48% |
| Jun 30, 2024 | -28.55% |
| Mar 31, 2024 | -26.43% |
| Dec 31, 2023 | -20.76% |
| Sep 30, 2023 | -50.47% |
| Jun 30, 2023 | -12.40% |
| Mar 31, 2023 | -103.13% |
| Dec 31, 2022 | -101.90% |
| Sep 30, 2022 | -48.53% |
| Jun 30, 2022 | -72.46% |
| Mar 31, 2022 | -37.70% |
| Dec 31, 2021 | 39.91% |
| Sep 30, 2021 | -48.94% |
| Jun 30, 2021 | -8.32% |